Arecor Therapeutics (AREC.LSE) Q3 2025 Earnings

25SepConfirmed
Q2 2024
Q3 2024
Q2 2025
Q3 2025
-14.14
-11.83
-9.52
-7.21

Details

Expected EPS
N/A
Actual EPS
-7.205470272
Surprise EPS
-7.21
Surprise Percent
+∞%

Description

Arecor Therapeutics (AREC.LSE) has reported earnings of -7.205470272 per share for Q3 2025.

0 Comments

Share your thoughts